Agios Pharmaceuticals | AGIO - 普通股股本



金融业
股票价格
USD
资产
USD 1.11B
现金及等价物
USD 99.65M
销售成本
USD 1.32M
流动资产
USD 717.67M
流动负债
USD 70.22M
债务
USD 35.75M
EBIT
USD -110.03M
EBITDA
USD -108.66M
员工
486
EPS每股收益
USD -1.69
股本和储备
USD 1.03B
销售毛利
USD 19.43M
债务利息支出
USD 1.11B
利息收入
USD 10.8M
贷款资金
USD 1.06M
市值
USD 1.89B
净收入
USD -99.11M
营业费用
USD 130.77M
营业利润
USD -110.03M
普通股股本
USD 59.34M
PE价格收益
3.56
税前利润
USD -99.11M
销售收入
USD 44.74M
销售和管理费用
USD 38.46M
股票
USD 35.75M
贸易债权人
USD 16.35M
应收帐款人
USD 16.13M


普通股股本 更改 日
AbbVie USD 1.77B 1.75B 2025-06
Agios Pharmaceuticals USD 59.34M 892K 2026-03
Alnylam Pharmaceuticals USD 133.73M 290K 2026-06
Amgen USD 541M 1000K 2026-06
Arrowhead Research USD 141.14M 564K 2026-06
Astellas Pharma JPY 1.79B 1.52M 2026-06
AstraZeneca USD 1.55B 44K 2026-06
Bayer EUR 982.42M 0 2026-06
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 193.54M 267K 2026-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Daiichi Sankyo JPY 1.82B 30.68M 2026-06
Eli Lilly USD 943.5M 3.33M 2026-03
Exelixis USD 248.88M 4.82M 2026-06
Gilead Sciences USD 1.24B 1000K 2026-06
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
Incyte USD 200.98M 1.03M 2026-06
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
Merck USD 2.47B 4.93M 2026-03
Moderna USD 391M 2M 2025-09
Nektar Therapeutics USD 29.47M 9.09M 2026-03
Novartis USD 1.9B 7.38M 2026-06
Novartis USD 1.91B 60K 2026-03
Pfizer USD 5.7B 0 2026-06
Puma Biotechnology USD 5K 0 2024-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Sarepta Therapeutics USD 105.62M 53K 2026-06
Vertex Pharmaceuticals USD 253.3M 900K 2026-06